Home » Topics » BioWorld Science

BioWorld Science
RSS

Cephamycins treat spore-forming bacteria, prevent relapses

Aug. 20, 2019

Sarepta Therapeutics receives complete response letter for golodirsen

Aug. 20, 2019

PD-1/PD-L1 interaction inhibitors patented by Bristol-Myers Squibb

Aug. 20, 2019

RAPT Therapeutics describes new C-C chemokine receptor type 4 antagonists

Aug. 20, 2019

Exelixis discovers AXL/Mer/c-Met inhibitors

Aug. 20, 2019

SU-011 improves glycemic control in vivo without the risk of hypoglycemia and weight gain

Aug. 20, 2019

Preclinical data presented for the novel re-engineered lupus autoantibody PAT-DX1

Aug. 20, 2019

Vanda receives complete response letter regarding sNDA for Hetlioz for treatment of jet lag disorder

Aug. 20, 2019

Positive recommendation to continue enrollment in phase Ib study of OTS Allocetra

Aug. 20, 2019

Phase II biomarker study of oral dexpramipexole in moderate to severe eosinophilic asthma

Aug. 20, 2019

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...